Abstract 1976 Bi-allelic inactivating variants of lactosylceramide synthase B4GALT5 responsible for a novel congenital disorder of glycosylation involving glycosphingolipids

A 7-year-old girl of Italian ancestry presenting with developmental delay, intellectual disability, microcephalia, and bilateral cataract was found to carry compound heterozygous variants in the B4GALT5 gene (deposited in Decipher: ID 412221) encoding a galactosyltransferase acting on glucosylceramide as substrate and producing lactosylceramide (LacCer), the precursors of the bulk of glycosphingolipids, including gangliosides and globosides. We wanted to establish if B4GALT5 variants expressed in the patient are responsible for disease pathogenesis defining a novel and unexpected congenital disorder of glycosylation (CDG).

Authors

Institutions

Publication Details

Journal
Journal of Biological Chemistry
Published
2025-05-01
DOI
https://doi.org/10.1016/j.jbc.2025.109330
Primary Topic
Glycosylation and Glycoproteins Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 1976 Bi-allelic inactivating variants of lactosylceramide synthase B4GALT5 responsible for a novel congenital disorder of glycosylation involving glycosphingolipids

Anna Caretti, Michele Dei, Marco Trinchera, Maria Antonietta De Matteis et al.
Journal of Biological Chemistry
Glycosylation and Glycoproteins Research
article

Abstract 1976 Bi-allelic inactivating variants of lactosylceramide synthase B4GALT5 responsible for a novel congenital disorder of glycosylation involving glycosphingolipids

Anna Caretti, Michele Dei, Marco Trinchera, Maria Antonietta De Matteis, Gerarda Cappuccio, Nicola Brunetti‐Pierri, Linda Montavoci
article en

Abstract

A 7-year-old girl of Italian ancestry presenting with developmental delay, intellectual disability, microcephalia, and bilateral cataract was found to carry compound heterozygous variants in the B4GALT5 gene (deposited in Decipher: ID 412221) encoding a galactosyltransferase acting on glucosylceramide as substrate and producing lactosylceramide (LacCer), the precursors of the bulk of glycosphingolipids, including gangliosides and globosides. We wanted to establish if B4GALT5 variants expressed in the patient are responsible for disease pathogenesis defining a novel and unexpected congenital disorder of glycosylation (CDG).

Journal of Biological ChemistryVol. 301(5)
Beth Israel Deaconess Medical Center (US)
Openalex Percentile: Top 88%
Glycosylation and Glycoproteins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract 1976 Bi-allelic inactivating variants of lactosylceramide synthase B4GALT5 responsible for a novel congenital disorder of glycosylation involving glycosphingolipids — Anna Caretti, Michele Dei, et al. · Journal of Biological Chemistry (2025) | TGRS Research Map | TGRS